Inhibikase Therapeutics shares owned by Zeke Capital Advisors
Quarter-by-quarter ownership of Inhibikase Therapeutics shares owned by Zeke Capital Advisors
from 13F filings
Historical chart of Zeke Capital Advisors investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Zeke Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Zeke Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-12-31 | $47k | 94k | 0.50 |
| 2022-09-30 | $85k | 94k | 0.91 |
| 2022-06-30 | $70k | 94k | 0.75 |
| 2022-03-31 | $139k | 94k | 1.48 |
| 2021-12-31 | $138k | 94k | 1.47 |
| 2021-09-30 | $178k | 94k | 1.90 |
| 2021-06-30 | $263k | 94k | 2.80 |
| 2021-03-31 | $113k | 19k | 6.01 |
| 2020-12-31 | $130k | 19k | 6.91 |